Safety and Efficacy of U3-1402 in Advanced or Metastatic Colorectal Cancer - Clinical Trial
What is the Purpose of this Study?
We are doing this study to see if the study drug, U3-1402, is safe and effective for shrinking your tumors.
Who Can Participate in the Study?
Adults with colorectal adenocarcinma who:
-Have advanced or metastatic disease
-Failed at least 2 prior lines of therapy
What is Involved?
If you choose to join this study, you will:
-Get the study drug, U3-1402, by I.V. once every 3 weeks
-Give blood and urine samples
-Have regular CT or MRI scans